← Back to Search

Treatment for Lung Cancer (TUMORIN Trial)

N/A
Recruiting
Research Sponsored by Jun Zhang, MD, PhD
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 years
Awards & highlights

Summary

To test whether it is feasible to perform the 3D-EX functional predictive response bioassay in the context of patients with advanced/metastatic NSCLC receiving immune checkpoint inhibitors in the standard of care clinical setting.

Eligible Conditions
  • Lung Cancer
  • Non-Small Cell Lung Cancer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 years for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Feasibility of establishing 3D ex-vivo tumoroid model
Secondary study objectives
Correlation of response in ex vivo tumoroids with clinical objective response

Find a Location

Who is running the clinical trial?

Jun Zhang, MD, PhDLead Sponsor
4 Previous Clinical Trials
190 Total Patients Enrolled
Nilogen OncosystemsIndustry Sponsor
1 Previous Clinical Trials
25 Total Patients Enrolled
~9 spots leftby Jan 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top